Document ID: 12165

Text:
(g) Capitalization. The capitalization of the Company is as set forth on Schedule 3.1(g). The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act , other than pursuant to the exercise of employee stock options under the Companys stock option plans, the issuance of shares of Common Stock to employees pursuant to the Companys employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act . No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Other than as disclosed in the Prospectus and the Prospectus Supplement, and except as a result of the purchase and sale of the Securities or as set forth on Schedule 3.1(g), there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. Except as set forth on Schedule 3.1(g), there are no securities of the Company or any Subsidiary that have an anti-dilution or similar adjustment rights (other than adjustments for stock splits, recapitalizations and the like) to the exercise or conversion price, have any exchange rights or reset rights. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or phantom stock plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Companys capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Companys stockholders.

Named Entities:
40
41
Act
104
105
Act
565
566
Title
568
569
Title

Tokenized Text:
(
g
)
Capitalization
.
The
capitalization
of
the
Company
is
as
set
forth
on
Schedule
3
.
1
(
g
)
.
The
Company
has
not
issued
any
capital
stock
since
its
most
recently
filed
periodic
report
under
the
Exchange
Act
,
other
than
pursuant
to
the
exercise
of
employee
stock
options
under
the
Companys
stock
option
plans
,
the
issuance
of
shares
of
Common
Stock
to
employees
pursuant
to
the
Companys
employee
stock
purchase
plans
and
pursuant
to
the
conversion
and
/
or
exercise
of
Common
Stock
Equivalents
outstanding
as
of
the
date
of
the
most
recently
filed
periodic
report
under
the
Exchange
Act
.
No
Person
has
any
right
of
first
refusal
,
preemptive
right
,
right
of
participation
,
or
any
similar
right
to
participate
in
the
transactions
contemplated
by
the
Transaction
Documents
.
Other
than
as
disclosed
in
the
Prospectus
and
the
Prospectus
Supplement
,
and
except
as
a
result
of
the
purchase
and
sale
of
the
Securities
or
as
set
forth
on
Schedule
3
.
1
(
g
)
,
there
are
no
outstanding
options
,
warrants
,
scrip
rights
to
subscribe
to
,
calls
or
commitments
of
any
character
whatsoever
relating
to
,
or
securities
,
rights
or
obligations
convertible
into
or
exercisable
or
exchangeable
for
,
or
giving
any
Person
any
right
to
subscribe
for
or
acquire
,
any
shares
of
Common
Stock
or
the
capital
stock
of
any
Subsidiary
,
or
contracts
,
commitments
,
understandings
or
arrangements
by
which
the
Company
or
any
Subsidiary
is
or
may
become
bound
to
issue
additional
shares
of
Common
Stock
or
Common
Stock
Equivalents
or
capital
stock
of
any
Subsidiary
.
The
issuance
and
sale
of
the
Securities
will
not
obligate
the
Company
or
any
Subsidiary
to
issue
shares
of
Common
Stock
or
other
securities
to
any
Person
(
other
than
the
Purchasers
)
and
will
not
result
in
a
right
of
any
holder
of
Company
securities
to
adjust
the
exercise
,
conversion
,
exchange
or
reset
price
under
any
of
such
securities
.
Except
as
set
forth
on
Schedule
3
.
1
(
g
)
,
there
are
no
securities
of
the
Company
or
any
Subsidiary
that
have
an
anti-dilution
or
similar
adjustment
rights
(
other
than
adjustments
for
stock
splits
,
recapitalizations
and
the
like
)
to
the
exercise
or
conversion
price
,
have
any
exchange
rights
or
reset
rights
.
There
are
no
outstanding
securities
or
instruments
of
the
Company
or
any
Subsidiary
that
contain
any
redemption
or
similar
provisions
,
and
there
are
no
contracts
,
commitments
,
understandings
or
arrangements
by
which
the
Company
or
any
Subsidiary
is
or
may
become
bound
to
redeem
a
security
of
the
Company
or
such
Subsidiary
.
The
Company
does
not
have
any
stock
appreciation
rights
or
phantom
stock
plans
or
agreements
or
any
similar
plan
or
agreement
.
All
of
the
outstanding
shares
of
capital
stock
of
the
Company
are
duly
authorized
,
validly
issued
,
fully
paid
and
nonassessable
,
have
been
issued
in
compliance
with
all
federal
and
state
securities
laws
,
and
none
of
such
outstanding
shares
was
issued
in
violation
of
any
preemptive
rights
or
similar
rights
to
subscribe
for
or
purchase
securities
.
No
further
approval
or
authorization
of
any
stockholder
,
the
Board
of
Directors
or
others
is
required
for
the
issuance
and
sale
of
the
Securities
.
There
are
no
stockholders
agreements
,
voting
agreements
or
other
similar
agreements
with
respect
to
the
Companys
capital
stock
to
which
the
Company
is
a
party
or
,
to
the
knowledge
of
the
Company
,
between
or
among
any
of
the
Companys
stockholders
.